The company behind the deadly 2022 infant formula outbreak and recall situation was represented by the man expected to be appointed to lead the FDA division that oversees food safety.
Kyle Diamantas, who joined the FDA as interim leader of the agency’s food division, was most recently a corporate attorney
Continue Reading Interim FDA food official represented firm behind infant formula outbreak
— OPINION —
The toxic baby food crisis is not just a failure in public health. It is a defining moral challenge for an industry entrusted with the most sacred responsibility: nourishing our children.
For years, warnings about heavy metals like lead, arsenic, and cadmium, coupled with pathogens such as
Continue Reading Leadership, accountability and the toxic baby food crisis
A bipartisan effort in the U.S. Senate seeks to improve the safety of infant formula.
Introduced by Sen. John Hoeven, R-ND, and Sen. Gary Peters, D-MI, the bill also seeks to prevent infant formula shortages.
The legislation is a reaction to a 2022 outbreak of cronobacter infections that sickened several
Continue Reading Legislation would increase safety of infant formula, help decrease shortages
In response to the infant formula supply crisis in 2022 and the deadly infections that led to it, the FDA has updated its infant formula compliance program.
An outbreak of Cronobacter infections in five infants, two of whom died, started in the fall of 2021 and stretched into early 2022.
Continue Reading FDA issues new compliance measures for infant formula testing and reporting
Top FDA officials are calling on manufacturers of infant formula to clean up their act.
In a letter this week Robert M. Califf, FDA Commissioner, and Susan T. Mayne, Director of the Center for Food Safety and Applied Nutrition, addressed concerns about infant formula along the food chain, speaking to
Continue Reading FDA wants infant formula manufacturers to step up work to prevent contamination
Abbott Nutrition’s Chairman, and Chief Executive Officer, Robert Ford has announced that his company is putting up $500 million for a new infant formula manufacturing facility at a location yet to be determined.
His announcement came during a quarterly phone conference with investment analysts as the troublesome infant formula shortages
Continue Reading Abbott Nutrition puts up $500 million for new state of art baby formula production